News

Personalized predictive model improves risk assessment for coronary artery disease
Coronary artery disease (CAD) is the leading cause of death in the United States. Although effective preventive treatments ...
Labmate Online4d
‘Clearly Rosy had to go, or be put in her place’ – Photograph 51 and the injustices that lay at the heart of discovering DNA
Is Rosalind Franklin a ghost that still haunts the history of genomic science? Alan Booth looks into her remarkable story ...
Clinical Trials Arena5d
DSMB recommends continuation of BioCardia’s cell therapy trial for heart failure
An independent Data Safety Monitoring Board (DSMB) has recommended the continuation of BioCardia's Phase I/II CardiALLO-HF ...
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of ...